Andrew LeBlanc

Andrew is a second-year graduate student in the Wuest Lab.

Andrew grew-up in Portland, Maine before moving to Cincinnati where he earned his B.S. from Xavier University. While at Xavier, Andrew worked under the direction of Dr. Richard Mullins on the Formal Synthesis of Kalkitoxin—a potent marine natural product. 

Currently, Andrew is interested in the total synthesis and biological evaluation of complex molecules.

“Andy’s skills to navigate natural product total synthesis rival the best students I have worked with over my two decades in the field,” says Dr. Bill Wuest. “He has a tremendously high ceiling in this arena! His ability to pivot and reroute his total synthesis are well beyond his years and validates his
prior rigor in training and classroom studies.”

Andy’s ability to formulate and present new ideas was recently recognized with a Biological Discoveries through Chemical Innovation (BDCI) seed grant in partnership with John Talbott from the Raj Group.

“[Andrew’s] ability to pivot and reroute his total synthesis are well beyond his years and validates his prior rigor in training and classroom studies.”

Dr. Bill Wuest

Andy’s NSF GRFP proposal was centered around the total synthesis of a novel antimicrobial compound and chemical biology techniques to elucidate its unknown mechanism of action.

Outside of the lab, Andrew enjoys hanging out with friends, pickle ball, and playing chess.

Congratulations, Andrew!